Exploring Structural Determinants of Bias among D4 Subtype-Selective Dopamine Receptor Agonists

被引:3
|
作者
Grassl, Fabian
Bock, Leonard [1 ]
Gonzalez, Alvaro Huete-Huerta [1 ]
Schiller, Martin [1 ]
Gmeiner, Peter [1 ]
Koenig, Joerg [2 ]
Fromm, Martin F. [2 ]
Huebner, Harald [1 ]
Heinrich, Markus R. [1 ]
机构
[1] Friedrich Alexander Univ Erlangen Nurnberg, Dept Chem & Pharm, Pharmaceut Chem, D-91058 Erlangen, Germany
[2] Friedrich Alexander Univ Erlangen Nurnberg, Inst Expt & Clin Pharmacol & Toxicol, D-91054 Erlangen, Germany
关键词
D-4; RECEPTOR; ANOREXIA-NERVOSA; 7-REPEAT ALLELE; PENILE ERECTION; P-GLYCOPROTEIN; D2; DISCOVERY; GENE; HYPERACTIVITY; POLYMORPHISMS;
D O I
10.1021/acs.jmedchem.3c00537
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The high affinity dopamine D-4 receptor ligandAPH199and derivatives thereof exhibit bias toward the G(i) signalingpathway over & beta;-arrestin recruitment compared to quinpirole.Based on APH199, two novel groups of D-4 subtype selectiveligands were designed and evaluated, in which the original benzylphenylsemicarbazide substructure was replaced by either a biphenylmethylurea or a biphenyl urea moiety. Functional assays revealed a rangeof different bias profiles among the newly synthesized compounds,namely, with regard to efficacy, potency, and GRK2 dependency, inwhich bias factors range from 1 to over 300 and activation from 15%to over 98% compared to quinpirole. These observations demonstratethat within bias, an even more precise tuning toward a particularprofile is possible, which in a general sense couldbecome an important aspect in future drug development. Docking studiesenabled further insight into the role of the ECL2 and the EPB in theemergence of bias, thereby taking advantage of the diversity of functionallyselective D-4 agonists now available.
引用
收藏
页码:9710 / 9730
页数:21
相关论文
共 50 条
  • [21] Development of subtype-selective nicotinic receptor ligands as receptor antagonists at the dopamine-releasing receptor subtype.
    Crooks, PA
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2004, 228 : U911 - U911
  • [22] Effects of estrogen receptor subtype-selective agonists on immune functions in ovariectomized mice
    Li, Jing
    McMurray, Robert W.
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2006, 6 (09) : 1413 - 1423
  • [23] The potential of subtype-selective neuronal nicotinic acetylcholine receptor agonists as therapeutic agents
    Lloyd, GK
    Menzaghi, F
    Bontempi, B
    Suto, C
    Siegel, R
    Akong, M
    Stauderman, K
    Velicelebi, G
    Johnson, E
    Harpold, MM
    Rao, TS
    Sacaan, AI
    Chavez-Noriega, LE
    Washburn, MS
    Vernier, JM
    Cosford, NDP
    McDonald, LA
    LIFE SCIENCES, 1998, 62 (17-18) : 1601 - 1606
  • [24] CHARACTERIZATION OF ADENOSINE RECEPTOR SUBTYPE-SELECTIVE AGONISTS IN THE RAT HINDQUARTERS VASCULAR BED
    DUNHAM, EW
    GEORGY, SS
    FASEB JOURNAL, 1991, 5 (06): : A1768 - A1768
  • [25] Retinoid receptor subtype-selective modulators through synthetic modifications of RARγ agonists
    Alvarez, Susana
    Alvarez, Rosana
    Khanwalkar, Harshal
    Germain, Pierre
    Lemaire, Geraldine
    Rodriguez-Barrios, Fatima
    Gronemeyer, Hinrich
    de Lera, Angel R.
    BIOORGANIC & MEDICINAL CHEMISTRY, 2009, 17 (13) : 4345 - 4359
  • [26] Rapid identification of subtype-selective agonists of the somatostatin receptor through combinatorial chemistry
    Rohrer, SP
    Birzin, ET
    Mosley, RT
    Berk, SC
    Hutchins, SM
    Shen, DM
    Xiong, YS
    Hayes, EC
    Parmar, RM
    Foor, F
    Mitra, SW
    Degrado, SJ
    Shu, M
    Klopp, JM
    Cai, SJ
    Blake, A
    Chan, WWS
    Pasternak, A
    Yang, LH
    Patchett, AA
    Smith, RG
    Chapman, KT
    Schaeffer, JM
    SCIENCE, 1998, 282 (5389) : 737 - 740
  • [27] Dopamine D4 receptor ubiquitination
    Skieterska, Kamila
    Rondou, Pieter
    Van Craenenbroeck, Kathleen
    BIOCHEMICAL SOCIETY TRANSACTIONS, 2016, 44 : 601 - 605
  • [28] Dopamine D4 receptor antagonists
    Kulagowski, JJ
    Patel, S
    CURRENT PHARMACEUTICAL DESIGN, 1997, 3 (04) : 355 - 366
  • [29] Dopamine D4 receptor antagonist
    Lloyd, AW
    DRUG DISCOVERY TODAY, 1998, 3 (07) : 351 - 351
  • [30] Abolishing Dopamine D2long/D3 Receptor Affinity of Subtype-Selective Carbamoylguanidine-Type Histamine H2 Receptor Agonists
    Tropmann, Katharina
    Bresinsky, Merlin
    Forster, Lisa
    Moennich, Denise
    Buschauer, Armin
    Wittmann, Hans-Joachim
    Huebner, Harald
    Gmeiner, Peter
    Pockes, Steffen
    Strasser, Andrea
    JOURNAL OF MEDICINAL CHEMISTRY, 2021, 64 (12) : 8684 - 8709